Anúncio
Anúncio
PVLA
Palvella Therapeutics, Inc. Common Stock
92.39
USDPatrocinado
-4.99
-5.13%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
93.40
+1.01
+1.10%
Relatórios de Lucros PVLA
Rácio de surpresa positiva
PVLA separação 22 de 36 últimas estimativas.
61%
Próximo Relatório
Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.91
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-11.65%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-66.54%
Palvella Therapeutics, Inc. Common Stock earnings per share and revenue
On 11 de nov. de 2025, PVLA reported earnings of -1.03 USD per share (EPS) for Q3 25, missing the estimate of -0.85 USD, resulting in a -20.45% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analistas forecast an EPS of -0.91 USD, with revenue projected to reach -- USD, implying an diminuir of -11.65% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Palvella Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Palvella Therapeutics, Inc. Common Stock reported EPS of -$1.03, missing estimates by -20.45%, and revenue of $0.00, 0% as expectations.
How did the market react to Palvella Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -3.04%, changed from $80.29 before the earnings release to $77.85 the day after.
When is Palvella Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 30 de mar. de 2026.
What are the forecasts for Palvella Therapeutics, Inc. Common Stock's next earnings report?
Based on 17
analistas, Palvella Therapeutics, Inc. Common Stock is expected to report EPS of -$0.91 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio